Total Payments
$1,965
2022 Payments
$53.78
Companies
19
Transactions
74
Medicare Patients
12,556
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$1,965 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,965 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $663.01 | 17 | $0 (2018) |
| Hollister Incorporated | $255.25 | 10 | $0 (2018) |
| Integra LifeSciences Corporation | $194.06 | 14 | $0 (2018) |
| Nestle HealthCare Nutrition Inc. | $149.44 | 6 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $125.59 | 1 | $0 (2019) |
| Smith & Nephew, Inc. | $104.40 | 6 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $83.49 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.08 | 3 | $0 (2021) |
| Stryker Corporation | $56.59 | 1 | $0 (2020) |
| TEI Medical Inc. | $54.23 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $53.78 | 2 | Nestle HealthCare Nutrition Inc. ($53.78) |
| 2021 | $233.49 | 10 | Nestle HealthCare Nutrition Inc. ($95.66) |
| 2020 | $139.77 | 6 | Stryker Corporation ($56.59) |
| 2019 | $125.59 | 1 | Avanir Pharmaceuticals, Inc. ($125.59) |
| 2018 | $224.60 | 9 | AstraZeneca Pharmaceuticals LP ($83.49) |
| 2017 | $1,188 | 46 | Organogenesis Inc. ($616.52) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/20/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/12/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/06/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: DIABETES | ||||||
| 06/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: DIABETES | ||||||
| 05/20/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/10/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: DIABETES | ||||||
| 10/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiovascular | ||||||
| 09/01/2020 | FIDIA PHARMA USA INC. | Hymovis (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Osteoarthritis | ||||||
| 06/18/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/04/2020 | Stryker Corporation | T2 (Device) | Food and Beverage | Cash or cash equivalent | $56.59 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 04/25/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $125.59 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/26/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $83.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2018 | Integra LifeSciences Corporation | OMNIGRAFT (Device), PRIMATRIX, MEDIHONEY | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 05/11/2018 | Derma Sciences, Inc. | AMNIOEXCEL (Device), TCC-EZ, PRIMATRIX | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 03/29/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: Podiatry | ||||||
| 03/28/2018 | Hollister Incorporated | ENDOFORM (Device), HYDROFERA | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: WOUNDCARE | ||||||
| 03/23/2018 | TEI Medical Inc. | PRIMATRIX (Device), NON APPLICABLE, TCC-EZ | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: RECON-SKIN AND WOUND | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,707 | 5,520 | $561,156 | $334,728 |
| 2022 | 16 | 2,628 | 5,061 | $517,790 | $312,620 |
| 2021 | 23 | 3,948 | 7,187 | $636,482 | $367,033 |
| 2020 | 23 | 3,273 | 4,899 | $445,661 | $254,522 |
Total Patients
12,556
Total Services
22,667
Medicare Billing
$1.3M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 379 | 1,145 | $128,512 | $72,097 | 56.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 420 | 1,052 | $89,538 | $65,893 | 73.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 216 | 612 | $58,850 | $38,615 | 65.6% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 547 | 983 | $66,310 | $38,292 | 57.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 250 | 260 | $42,740 | $29,145 | 68.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 259 | $39,880 | $19,680 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 133 | $27,790 | $14,630 | 52.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 121 | 123 | $21,690 | $13,841 | 63.8% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 95 | 197 | $16,485 | $10,433 | 63.3% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 133 | 133 | $14,837 | $8,515 | 57.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Facility | 2023 | 189 | 348 | $23,700 | $6,800 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,480 | $6,215 | 54.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 52 | $9,364 | $5,660 | 60.4% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 40 | 62 | $5,005 | $3,026 | 60.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Facility | 2023 | 37 | 79 | $3,115 | $1,431 | 45.9% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Facility | 2023 | 23 | 35 | $1,860 | $455.00 | 24.5% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 333 | 945 | $114,712 | $72,833 | 63.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 408 | 970 | $82,031 | $55,810 | 68.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 212 | 663 | $63,964 | $38,626 | 60.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 592 | 982 | $63,380 | $37,119 | 58.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 196 | 202 | $33,220 | $21,845 | 65.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 272 | $39,230 | $20,386 | 52.0% |
| 99325 | New patient custodial care facility, group care, or assisted living visit, typically 30 minutes | Office | 2022 | 178 | 178 | $20,036 | $11,679 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 87 | $18,390 | $9,718 | 52.8% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 87 | 143 | $13,060 | $8,400 | 64.3% |
About Luke Won
Luke Won is a Foot & Ankle Surgery healthcare provider based in Santa Ana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1144625823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Luke Won has received a total of $1,965 in payments from pharmaceutical and medical device companies, with $53.78 received in 2022. These payments were reported across 74 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,965).
As a Medicare-enrolled provider, Won has provided services to 12,556 Medicare beneficiaries, totaling 22,667 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot & Ankle Surgery
- Location Santa Ana, CA
- Active Since 10/24/2014
- Last Updated 09/25/2019
- Taxonomy Code 213ES0103X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144625823
Products in Payments
- Apligraf (Device) $596.88
- ENDOFORM (Device) $242.46
- ZENPEP (Drug) $149.44
- NUEDEXTA (Drug) $125.59
- Santyl (Drug) $90.28
- FARXIGA (Drug) $83.49
- JARDIANCE (Drug) $83.08
- Omnigraft (Device) $81.11
- Primatrix (Device) $79.77
- Apligraf (Biological) $66.13
- T2 (Device) $56.59
- OMNIGRAFT (Device) $39.94
- XARELTO (Drug) $36.77
- ANORO ELLIPTA (Drug) $29.21
- Flowable (Device) $28.25
- Vascepa (Drug) $20.63
- TEFLARO (Drug) $20.28
- PRIMATRIX (Device) $19.22
- Hymovis (Device) $18.75
- VRAYLAR (Drug) $17.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Foot & Ankle Surgery Doctors in Santa Ana
Dr. Amir Lebaschi, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $10,124
Foot & Ankle Surgery $10,124
Paul Han, Dpm, DPM
Foot & Ankle Surgery — Payments: $290.05
Foot & Ankle Surgery $290.05
Virgil Hernandez, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $53.50
Foot & Ankle Surgery $53.50
Dr. Steven Ris, D.p.m, D.P.M
Foot & Ankle Surgery
Foot & Ankle Surgery